Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Terminated 2Recruiting 1Completed 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Prostatic Neoplasms 12Leukemia 12Lymphoma 7Burkitt Lymphoma 7Leukemia, Biphenotypic, Acute 6Lymphoma, Large B-Cell, Diffuse 5Recurrence 4Lymphoma, Non-Hodgkin 4Pituitary Neoplasms 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell 3Leukemia, Myeloid, Acute 3Hodgkin Disease 3Rhabdoid Tumor 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Obesity 2Neoplasms 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Hematologic Neoplasms 2Radiodermatitis 1Pyloric Stenosis, Hypertrophic 1Plasmablastic Lymphoma 1Pituitary Diseases 1Pinealoma 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Recurrence × Hydrocortisone × Clear all
NCT05292664 2026-03-12

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Dana-Farber Cancer Institute

Phase 1 Recruiting
30 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01186328 2024-02-01

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Terminated
6 enrolled 11 charts
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01614197 2023-07-27

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Completed
16 enrolled 16 charts
LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Lymphoma, T-Cell, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02535806 2019-08-13

Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults

Children's Mercy Hospital Kansas City

Phase 2 Terminated
2 enrolled 11 charts
LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡